Treatment for intracerebral hemorrhage: Dawn of a new era

医学 随机对照试验 脑出血 重症监护医学 冲程(发动机) 血肿 格拉斯哥昏迷指数 外科 机械工程 工程类
作者
David Seiffge,Craig S. Anderson
出处
期刊:International Journal of Stroke [SAGE]
卷期号:19 (5): 482-489 被引量:2
标识
DOI:10.1177/17474930241250259
摘要

Intracerebral hemorrhage (ICH) is a devastating disease, causing high rates of death, disability, and suffering across the world. For decades, its treatment has been shrouded by the lack of reliable evidence, and consequently, the presumption that an effective treatment is unlikely to be found. Neutral results arising from several major randomized controlled trials had established a negative spirit within and outside the stroke community. Frustration among researchers and a sense of nihilism in clinicians has created the general perception that patients presenting with ICH have a poor prognosis irrespective of them receiving any form of active management. All this changed in 2023 with the positive results on the primary outcome in randomized controlled trials showing treatment benefits for a hyperacute care bundle approach (INTERACT3), early minimal invasive hematoma evacuation (ENRICH), and use of factor Xa-inhibitor anticoagulation reversal with andexanet alfa (ANNEXa-I). These advances have now been extended in 2024 by confirmation that intensive blood pressure lowering initiated within the first few hours of the onset of symptoms can substantially improve outcome in ICH (INTERACT4) and that decompressive hemicraniectomy is a viable treatment strategy in patients with large deep ICH (SWITCH). This evidence will spearhead a change in the perception of ICH, to revolutionize the care of these patients to ultimately improve their outcomes. We review these and other recent developments in the hyperacute management of ICH. We summarize the results of randomized controlled trials and discuss related original research papers published in this issue of the International Journal of Stroke. These exciting advances demonstrate how we are now at the dawn of a new, exciting, and brighter era of ICH management.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
fmwang完成签到,获得积分10
1秒前
yongkun发布了新的文献求助10
1秒前
1秒前
ttt完成签到,获得积分10
1秒前
ming发布了新的文献求助10
1秒前
王金金发布了新的文献求助10
1秒前
2秒前
风趣访卉完成签到,获得积分10
2秒前
榴莲完成签到,获得积分10
2秒前
2秒前
zhang005on发布了新的文献求助10
3秒前
3秒前
斯文败类应助黎小静采纳,获得10
5秒前
英俊的铭应助王金金采纳,获得10
5秒前
更深的蓝911完成签到,获得积分20
7秒前
13508104971发布了新的文献求助10
7秒前
7秒前
大模型应助yl采纳,获得10
7秒前
psj发布了新的文献求助10
8秒前
马蹄发布了新的文献求助10
8秒前
WWXWWX应助style_fire采纳,获得10
9秒前
加油完成签到 ,获得积分10
9秒前
Leonardi应助guoxingliu采纳,获得200
10秒前
10秒前
不想看文献完成签到,获得积分10
10秒前
10秒前
喜屿完成签到 ,获得积分10
11秒前
11秒前
11秒前
12秒前
luo完成签到,获得积分10
12秒前
记忆里的阳光完成签到,获得积分10
13秒前
13508104971完成签到,获得积分10
13秒前
Yziii应助不想看文献采纳,获得20
14秒前
罗小学发布了新的文献求助10
14秒前
psj完成签到,获得积分10
15秒前
zzj完成签到,获得积分10
15秒前
chen发布了新的文献求助10
15秒前
孔乾发布了新的文献求助10
16秒前
细腻黎云完成签到 ,获得积分10
16秒前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Le dégorgement réflexe des Acridiens 800
Defense against predation 800
A Dissection Guide & Atlas to the Rabbit 600
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3134302
求助须知:如何正确求助?哪些是违规求助? 2785212
关于积分的说明 7770748
捐赠科研通 2440808
什么是DOI,文献DOI怎么找? 1297536
科研通“疑难数据库(出版商)”最低求助积分说明 624987
版权声明 600792